- New project aims to speed up process of finding treatments for chronic obstructive pulmonary disease (COPD), asthma and pulmonary fibrosis
- Scientists at the University of Leicester, University of Nottingham and University of Cambridge, will connect data science, genomics and laboratory research for the first time in tackling lung conditions
- New genetic markers of lung function to be identified, which will provide new targets for drug development
- Chronic respiratory disease, such as COPD, is the third leading cause of death globally
A medicine licensed to treat psoriasis worsened symptoms in patients with severe asthma, according to trial results published today in the New England Journal of Medicine.Read More
An international team of scientists, led by the Universities of Leicester and Glasgow, has announced findings that could pave the way to a new treatment for asthma and chronic obstructive pulmonary disease (COPD).Read More
Patients in the East Midlands with respiratory illnesses including asthma and COPD will benefit from a pioneering data hub announced today.